WHO Pharmaceuticals Newsletter 2003, No. 04
(2003; 13 pages) Voir le document au format PDF
Table des matières
Fermer ce répertoireREGULATORY MATTERS
Afficher le documentABACAVIR, LAMIVUDINE, TENOFOVIR - Virologic non-response in HIV with combination therapy
Afficher le documentACETYL-SALICYLIC ACID (PAEDIATRIC) - OTC withdrawal
Afficher le documentACETYL-SALICYLIC ACID, PARACETAMOL, IRON - New packaging standards for improving child resistance
Afficher le documentBENZ-BROMARONE - Withdrawn due to reports of liver damage
Afficher le documentEZETIMIBE - Labelling update regarding hypersensitivity reactions
Afficher le documentLEFLUNOMIDE - Explicit liver function monitoring directions added to label
Afficher le documentPAROXETINE - Unfavourable risk benefit ratio in children and adolescents
Afficher le documentSALMETEROL - Risk of life-threatening asthma episodes
Afficher le documentSOMATROPIN (rDNA ORIGIN) - Reports of fatalities in paediatric patients with Prader-Willi syndrome
Afficher le documentTIROFIBAN - Advice against off-label use
Afficher le documentTOPIRAMATE - Risk of oligohidrosis and hyperthermia
Ouvrir ce répertoire et afficher son contenuSAFETY OF MEDICINES
Ouvrir ce répertoire et afficher son contenuDRUGS IN THE NEWS
 

ACETYL-SALICYLIC ACID, PARACETAMOL, IRON - New packaging standards for improving child resistance

UK. The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has announced that all products containing acetylsalicylic acid, paracetamol and iron will now be required to be in packaging that meets the new British Standard on child resistance for medicines. The new regulations will come into force on 1 October 2003 with a 2-year transitional period for products already on the market to comply. The proposal endorses an additional safeguard in keeping medicines out of children’s reach and is based on a 12-week public consultation exercise involving Pharmacy Colleges, the National Health Service, Industry, Medical Colleges and other professional bodies.

Reference:

MHRA Publication, Aug 2003. Available from URL: http://medicines.mhra.gov.uk

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013